VR Therapy Specialist Oxford VR Secures $12.5 Million Investment For US Expansion

When it comes to virtual reality (VR) applications some of the most interesting work is being conducted in the healthcare field. Oxford VR is a company developing immersive therapy for a range of conditions and to help in this process has recently announced the completion of a new investment round totalling $12.5 million USD. The Series A funding round was led by Optum Ventures and supported by Luminous Ventures with existing investors such as Oxford Sciences Innovation, Oxford University Innovation and GT Healthcare Capital Partners also participating. Oxford VR will use the funds to accelerate US expansion of its scalable automated VR therapy solutions for behavioural health issues. Additionally, Oxford VR will continue expanding work into conditions such as anxiety, depression and post-traumatic stress disorder.